COO · NASDAQ
The Cooper Companies, Inc.
$60.68 +2.67 (+4.53%)
Company overview
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lenses. The company operates in two segments: CooperVision and CooperSurgical. The CooperVision segment offers spherical lenses, including lenses that correct near and farsightedness, as well as toric and multifocal lenses that address vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigue, serving customers in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's healthcare, providing medical devices, fertility, genomics, diagnostics, and contraception products to healthcare professionals and patients worldwide.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NASDAQ
- Market cap
- $11.5B
- Employees
- 16,000
- Headquarters
- San Ramon, CA
- Website
- coopercos.com
- CEO
- Albert G. White
- Listed
- January 21, 1983
- P/E
- 30.06
- Dividend yield
- 0.02%
Company financials
- Revenue
- $4.2B
- Gross profit
- $2.7B
- Operating income
- $714M
- EBITDA
- $962M
- Net income
- $401M
- EPS
- $2.02
- Total assets
- $12.4B
- Total debt
- $2.5B
- Gross margin
- 64.24%
- Net margin
- 9.67%
- Earnings yield
- 3.33%
Showing FY 2025
COO
1D
NASDAQ
O61.27H61.74L60.52C61.22-0.43 (-0.70%)Vol529.57K